Informing clinical trial participants about study results

JAMA

Volumn 288, Issue 3, 2002, Pages 363-365

  Partridge, Ann H ^a   Winer, Eric P ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATTITUDE; CLINICAL TRIAL; ETHICS; HUMAN; INFORMED CONSENT; MEDICAL INFORMATION; NOTE; PRIORITY JOURNAL;

EID: 0037125416     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.3.363     Document Type: Note

References (29)

1. Cancer statistics
2. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials
3. Informing patients about clinical trials
4. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
5. Protecting communities in research: Current guidelines and limits of extrapolation
6. Participatory research with native community of Kahnawake creates innovative Code of Research Ethics
7. Participatory research maximises community and lay involvement
8. Bioethics Committee: Report and invitation
9. Participation in a clinical trial: The patients' point of view
10. Giving medicine a fair trial: Patients' altruism should be appreciated
11. Doctor-patient communication: A review of the literature
12. A prospective, randomized comparison of two doses of combination alkylating agents as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes
13. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer
14. Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma
15. Lives: Close to the bone
16. The rights of patients in research
17. Survival of patients with breast cancer attending Bristol Cancer Help Centre
18. The informational needs of patients with cancer and their families
19. Treatment decision making in women newly diagnosed with breast cancer
20. Relationship between preferences for decisional control and illness information among women with breast cancer: A quantitative and qualitative analysis
21. Decision making during serious illness: What role do patients really want to play?
22. What do we mean by partnership in making decisions about treatment?
23. False hopes and best data: Consent to research and the therapeutic misconception
24. Professional integrity in clinical research
25. Attitudes toward clinical trials among patients and the public